Hemodynamics-guided treatment of hypertensive disorders of pregnancy: systematic review and meta-analysis.
G P Novelli, B Vasapollo, R Attini et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review and meta-analysis evaluated the impact of hemodynamics-guided antihypertensive therapy on maternal and perinatal outcomes in women with hypertensive disorders of pregnancy (HDP). The analysis included six studies, revealing that hemodynamics-guided management significantly reduced the odds of pre-eclampsia/eclampsia by 53% (OR, 0.47; 95% CI, 0.33-0.65) compared to standard care.
Key findings
- Hemodynamics-guided therapy reduced the odds of pre-eclampsia/eclampsia by 53% (OR, 0.47; 95% CI, 0.33-0.65).
- Severe hypertension was reduced by 61% (OR, 0.39; 95% CI, 0.18-0.88).
- Fetal growth restriction decreased by 46% (OR, 0.54; 95% CI, 0.38-0.76).
- The composite adverse outcome had an OR of 0.27 (95% CI, 0.21-0.36).
Why it matters
The findings suggest that hemodynamics-guided management may lead to improved maternal and perinatal outcomes in women with hypertensive disorders of pregnancy, highlighting the potential for enhanced clinical strategies in this population.
What to keep in mind
The study's overall certainty of evidence was low to very low, primarily due to the predominance of non-randomized study designs and measurement heterogeneity.